← The Wire
ARQTNasdaq
Arcutis Biotherapeutics, Inc.
Pharmaceutical Preparations · DE · CIK 1787306
Develops and commercializes treatments for dermatological diseases with high unmet medical needs
$3.05B
Market cap
$26.76
Last close
-0.9%
1D
+0.4%
5D
1.4M
Volume
Price · last 39 sessions+13.9%
May 4L $19.50 · H $27.37Jun 29
144
Total filings
Jun 9, 2026
Last filing
12/31
Fiscal year end
8-KShareholder Vote · Company UpdateJun 9, 202610-Q10-QMay 6, 20268-KCompany UpdateMay 6, 2026DEFA14ADEFA14AApr 21, 2026DEF 14ADEF 14AApr 21, 202610-K10-KFeb 25, 20268-KResults of OperationsFeb 25, 20268-KExecutive Change · Reg FD DisclosureDec 8, 202510-Q10-QOct 28, 20258-KResults of OperationsOct 28, 202510-Q10-QAug 6, 20258-KResults of OperationsAug 6, 20258-KShareholder Vote · Company UpdateJun 17, 202510-Q10-QMay 6, 20258-KResults of OperationsMay 6, 2025DEFA14ADEFA14AApr 29, 2025DEF 14ADEF 14AApr 29, 20258-KExecutive Change · Reg FD DisclosureApr 10, 202510-K10-KFeb 25, 20258-KResults of OperationsFeb 25, 20258-KResults of OperationsJan 13, 202510-Q10-QNov 6, 20248-KResults of OperationsNov 6, 202410-Q10-QAug 14, 20248-KResults of OperationsAug 14, 202410-Q/A10-Q/AJul 24, 20248-KShareholder VoteJun 18, 202410-Q10-QMay 14, 20248-KResults of OperationsMay 14, 2024DEFA14ADEFA14AApr 26, 2024DEF 14ADEF 14AApr 26, 20248-KExecutive Change · Reg FD DisclosureApr 10, 20248-KCompany UpdateMar 4, 2024424B5424B5Mar 1, 2024424B5424B5Feb 28, 20248-KMaterial AgreementFeb 28, 202410-K10-KFeb 27, 20248-KResults of OperationsFeb 27, 20248-KExecutive ChangeFeb 15, 2024SC 13GSCHEDULE 13GFeb 13, 2024SC 13GMS INITIALFeb 12, 2024SC 13GSC 13GFeb 12, 2024424B5424B5Feb 8, 2024SC 13G13G INITIAL ANNUAL FILING - (ARQT)Feb 8, 2024SC 13GARCUTIS BIOTHERAPEUTICS, INC.Jan 31, 2024SC 13GSC 13GJan 29, 20248-KCompany UpdateJan 11, 20248-KCompany UpdateDec 18, 2023SC 13GSC 13GNov 16, 202310-Q10-QNov 3, 20238-KResults of OperationsNov 3, 2023SC 13GSC 13GOct 30, 20238-KCompany UpdateOct 23, 2023424B5424B5Oct 23, 2023424B5424B5Oct 19, 20238-KResults of Operations · Company UpdateOct 19, 20238-KExecutive Change · Reg FD DisclosureSep 27, 202310-Q/A10-Q/ASep 15, 202310-Q/A10-Q/ASep 15, 202310-K/A10-K/ASep 15, 20238-K/AExecutive ChangeSep 7, 20238-KExecutive Change · Reg FD DisclosureAug 18, 20238-KMaterial AgreementAug 14, 202310-Q10-QAug 8, 20238-KResults of OperationsAug 8, 20238-KShareholder VoteJun 5, 20238-KExecutive Change · Company UpdateMay 24, 202310-Q10-QMay 9, 20238-KResults of OperationsMay 9, 2023DEFA14ADEFA 14AApr 18, 2023DEF 14ADEF 14AApr 18, 202310-K10-KFeb 28, 20238-KResults of OperationsFeb 28, 2023SC 13GSC 13GFeb 8, 20238-KCompany UpdateDec 16, 202210-Q10-QNov 8, 20228-KResults of OperationsNov 8, 20228-KMaterial Agreement · New Debt / ObligationSep 7, 20228-KExecutive Change · Reg FD DisclosureSep 6, 20228-KCompany UpdateAug 5, 2022
Insider Activity
In the 90 days to Mar 2, 2026: 7 sold $5.8M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 2, 2026 | Leonard Keith RDirector | Sell | 39,272 | $25.39 | $997K |
| Mar 2, 2026 | Watanabe ToddSee Remarks | Sell | 36,281 | $25.16 | $913K |
| Mar 2, 2026 | Welgus Howard G.Director | Sell | 10,000 | $25.65 | $257K |
| Mar 2, 2026 | Matsuda MasaruSee Remarks | Sell | 6,553 | $25.16 | $165K |
| Mar 2, 2026 | Burnett PatrickSee Remarks | Sell | 6,106 | $25.16 | $154K |
| Mar 2, 2026 | Edwards Larry ToddSee Remarks | Sell | 3,584 | $25.16 | $90K |
| Mar 2, 2026 | Vairavan LathaSVP Chief Financial Officer | Sell | 2,772 | $25.16 | $70K |
| Mar 2, 2026 | Matsuda MasaruSee Remarks | Sell | 1,987 | $25.70 | $51K |
| Mar 2, 2026 | Watanabe ToddSee Remarks | Sell | 1,068 | $25.91 | $28K |
| Mar 2, 2026 | Matsuda MasaruSee Remarks | Sell | 193 | $25.91 | $5K |
| Mar 2, 2026 | Burnett PatrickSee Remarks | Sell | 181 | $25.91 | $5K |
| Mar 2, 2026 | Edwards Larry ToddSee Remarks | Sell | 103 | $25.91 | $3K |
| Mar 2, 2026 | Vairavan LathaSVP Chief Financial Officer | Sell | 81 | $25.91 | $2K |
| Feb 27, 2026 | Matsuda MasaruSee Remarks | Sell | 3,325 | $27.95 | $93K |
| Feb 4, 2026 | Burnett PatrickSee Remarks | Sell | 9,794 | $25.81 | $253K |
| Feb 2, 2026 | Watanabe ToddSee Remarks | Sell | 19,833 | $25.50 | $506K |
| Feb 2, 2026 | Matsuda MasaruSee Remarks | Sell | 19,379 | $25.24 | $489K |
| Feb 2, 2026 | Welgus Howard G.Director | Sell | 10,000 | $25.05 | $251K |
| Feb 2, 2026 | Matsuda MasaruSee Remarks | Sell | 8,562 | $24.97 | $214K |
| Feb 2, 2026 | Matsuda MasaruSee Remarks | Sell | 7,983 | $25.50 | $204K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance